ArticleAmerican journal of cancer research2021

Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.

Dan Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.